Related Experiment Video
Updated: Jun 24, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with
Annapoorna S Kini1, Kunal Sarkar, Oana C Rafael
1Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, New York, New York 10029-6574, USA.
Insights
A serum creatinine ratio greater than 1.5 after percutaneous coronary intervention predicts one-year mortality in patients with and without chronic renal insufficiency. This finding aids in risk stratification for patients undergoing revascularization procedures.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Contrast-induced nephropathy (CIN) increases mortality post-percutaneous revascularization.
- The impact of varying creatinine elevation levels on mortality in chronic renal insufficiency (CRI) patients is unclear.
- The relationship between post-PCI creatinine rise and mortality in patients with normal baseline renal function requires investigation.
Purpose of the Study:
- To investigate the correlation between different serum creatinine (SCr) elevation levels and 1-year mortality after percutaneous coronary intervention (PCI).
- To determine if this correlation differs between patients with chronic renal insufficiency (CRI) and those with normal baseline renal function.
Main Methods:
- Analysis of 12,997 PCI patients, divided into CRI (baseline SCr ≥ 1.5 mg/dl) and normal baseline renal function (BSC < 1.5 mg/dl) groups.
- Patients were subgrouped by serum creatinine ratio (SCrR = peak SCr/Baseline SCr): <1.25, 1.25-1.5, and >1.5.
- Cox hazard modeling was used to assess variables associated with 1-year mortality.
Main Results:
- Overall CIN incidence was 5.9% (11.3% in CRI vs. 5.1% in normal BSC group).
- Only SCrR > 1.5 was significantly correlated with increased 1-year mortality.
- This association was consistent in both CRI and normal baseline renal function groups.
Conclusions:
- A serum creatinine ratio (SCrR) greater than 1.5 is a predictor of 1-year mortality following PCI.
- This predictive value holds for patients with both chronic renal insufficiency and normal baseline renal function.
- SCrR serves as a valuable tool for risk stratification and prognostication in post-PCI patients.
Unlabelled:
The occurrence of contrast induced nephropathy (CIN) is associated with increased mortality after percutaneous revascularization procedures. However, the exact correlation between various levels of creatinine elevation relative to the baseline and subsequent mortality in patients with chronic renal insufficiency (CRI) is not well established. In addition, the relationship between elevated postprocedural creatinine and ensuing mortality in patients with normal baseline renal function needs to be investigated.
Methods:
All percutaneous coronary intervention (PCI) patients (n = 12,997) were analyzed for any rise in serum creatinine (SCr): CRI group (BSC > or = 1.5 mg/dl) (n = 1,853) and normal baseline renal function (NBR BSC < 1.5 mg/dl) group (n = 11,144). Patients in each group were analyzed for any elevation in SCr postprocedure and subdivided based on the SCr ratio [peak SCr/Baseline creatinine (BSC)] of <1.25, 1.25-1.5, and >1.5. The overall incidence of CIN (defined as an increment of 25% over baseline creatinine) was 5.9%: 11.3% in the CRI group versus 5.1% in normal BSC group (P < 0.01). Recursive partitioning and Cox hazard modeling were used to assess significant variables associated with mortality within 1 year. Only serum creatinine ratio (SCrR) > 1.5 correlated with increased mortality in both CRI group as well as normal BSC group.
Conclusions:
SCrR > 1.5 predicts mortality at 1 year after PCI. The association between SCrR > 1.5 and increased mortality at follow-up is observed in patients with CRI as well as normal baseline renal function. SCrR may thus serve as a useful clinical tool for risk stratification and prognostication of patients after PCI.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Serum Studies: Renal Function Tests
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury IV: Diagnostic Studies and Prevention